Discover how to design compact, low-power continuous glucose monitors that enhance patient comfort and extend battery life.

A number of stocks fell in the afternoon session after worries over worsening trade relations with China were triggered by ...

DexCom, Inc. (NASDAQ:DXCM) is one of the best growth stocks to buy and hold forever. On September 22, UBS reiterated a ‘Buy’ rating on the stock and a $106 price target. The research firm reiterated ...

Investing.com - UBS maintained its Buy rating and $106.00 price target on DexCom (NASDAQ:DXCM) following a Friday sell-off triggered by concerns about the company’s G7 continuous glucose monitoring ...

As the effects of climate change and ecological decline intensify, the need for accurate, scalable environmental monitoring has never been more urgent. From tracking urban air quality to safeguarding ...

This episode covers routine service on the BMW E39 M5, including a full oil change and the replacement of the oil level sensor. The S62 V8 engine receives fresh fluids and inspection to keep the car ...

The Federal Circuit upheld an administrative tribunal’s decision to nix six claims from a DexCom Inc. patent covering implantable sensors used to monitor patients’ blood glucose levels. DexCom sued ...

DexCom has a well-established record of introducing the most precise sensors for use in its continuous glucose monitors. On the strength of its technology, DexCom has captured an impressive slice of ...

The U.S. FDA’s March 4, 2025, warning letter to Dexcom Inc. is a well-detailed but heavily redacted document explaining the agency’s misgivings about procedures such as monitoring of acetaminophen ...